{"id":7149,"date":"2023-01-11T11:52:18","date_gmt":"2023-01-11T10:52:18","guid":{"rendered":"https:\/\/bio-pat.org\/?p=7149"},"modified":"2023-01-11T12:03:31","modified_gmt":"2023-01-11T11:03:31","slug":"fyonibio-signed-service-agreement-with-adivo-gmbh","status":"publish","type":"post","link":"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh","title":{"rendered":"FyoniBio signed Service Agreement with Adivo GmbH"},"content":{"rendered":"

FyoniBio GmbH<\/a>, member of the Bio-PAT network<\/a>, signed a Service Agreement with adivo.It covers<\/span><\/span> the generation of a production cell line for their canine therapeutic mAb candidate.<\/p>\n

For the project, FyoniBio will use its versatile CHOnamite\u00ae cell line development platform, that integrates a high-performance Transposase technology and comprises various host
\ncell lines to select the most suitable cell line to produce adivo\u2019s canine mAb format at the highest quality and yield.<\/p>\n

 <\/p>\n

Press release<\/strong><\/p>\n

Berlin, Germany and<\/span> Munich<\/span>,<\/span> Germany<\/span>,<\/span> January<\/span> 1<\/span>0,<\/span> 202<\/span>3<\/span><\/span><\/strong><\/p>\n

FyoniBio<\/span>, a CDO expert specialized in tailored cell line development and adivo a leader in<\/span> discovering species<\/span>–<\/span>specific therapeutic antibodies for pets are pleased to announce the<\/span> signing of a cell line development agreement. adivo is transitioning its most advanc<\/span>ed<\/span> proprietary therapeutic<\/span> canine mAb<\/span> candidate, which has been granted the limited<\/span> market authorization status by the European Medicines Agency (EMA) into first<\/span>–<\/span>in<\/span>–<\/span>animal<\/span> studies.<\/span><\/span><\/p>\n

For the project, FyoniBio will use its versatile CHOnamite<\/span>\u00ae<\/span> cell line devel<\/span>opment platform<\/span>,<\/span> that integrates a high<\/span>–<\/span>performance Transposase technology and<\/span> compri<\/span>ses<\/span> various host<\/span> cell lines to select the most suitable cell line<\/span> to produce<\/span> a<\/span>divo<\/span>‘s<\/span> canine<\/span> mAb format<\/span> at<\/span> the <\/span>highest<\/span> quality and yield.<\/span><\/span><\/p>\n

“<\/span>We are delighted with this very collaborative project partnership with<\/span> a<\/span>divo, which<\/span> demonstrates an excellent fit between the project teams on both sides and that ou <\/span>CHOnamite<\/span>\u00ae<\/span> platform is ideally suited to generate highly productive cell lines for canine<\/span> antibodies as well<\/span>,<\/span>\u201d<\/span> outlined Dr. Lars St<\/span>\u00f6<\/span>ckl, Managing Director at FyoniBio.<\/span><\/span><\/span><\/p>\n

\u201c<\/span>We are excited to work with FyoniBio, whom we have chosen for their extensive <\/span>experience in biopharma development and their ability to provide tailor<\/span>–<\/span>made services for<\/span> companie<\/span>s of various sizes and at different development stages<\/span>.<\/span> Advancing a product<\/span> candidate from lab<\/span>–<\/span>scale manufacturing to providing trial<\/span>–<\/span>grade material is a pressure<\/span> test for any therapeutic project and a significant value inflection point,<\/span>\u201c<\/span> commented Dr.<\/span> Phi<\/span>lipp Baer, Chief Scientific Officer of adivo.<\/span><\/span> <\/span><\/p>\n

 <\/p>\n

FyoniBio Facts<\/span><\/span><\/strong><\/p>\n

<\/span>FyoniBio<\/span>\u2019<\/span>s<\/span> ISO<\/span>–<\/span>9001 certified service portfolio covers the development chain from cell line <\/span>development, process development and in<\/span>–<\/span>depth analytical characterization, including <\/span>bioassays and clinical sample monitoring under GCLP. FyoniBio<\/span>\u2019<\/span>s expertise builds on the<\/span> l<\/span>ong<\/span>–<\/span>standing experience of our scientists who have developed various cell lines and<\/span> processes<\/span> which<\/span> entered late<\/span>–<\/span>stage clinical trials. Our customized approaches enable<\/span> rapid, high<\/span>–<\/span>titer cell line development in various mammalian host cell lines specialize<\/span>d<\/span> in<\/span> meeting individual product requirements. Besides our CHOnamite<\/span>\u00ae<\/span> platform, we provide<\/span> the human GEX<\/span>\u00ae<\/span> platform, which is particularly suited for recombinant proteins with<\/span> complex glycan structures. Further<\/span>more<\/span> FyoniBio is highly skilled<\/span> in<\/span> mass spectrom<\/span>etry<\/span> based in<\/span>–<\/span>depth analytical characterization of biopharmaceutical<\/span>s<\/span> and offers the whole<\/span> package of clinical sample analysis from assay establishment, validation and measurement<\/span> of clinical samples under GCLP.<\/span><\/span><\/p>\n

<\/span>All services are established according<\/span> to<\/span> o<\/span>ur internal quality management system to <\/span>assure compliance with international ISO standard and meeting international GMP<\/span> standards.<\/span><\/span><\/span>
<\/span><\/p>\n

 <\/p>\n

a<\/span>divo<\/span> Facts<\/span><\/strong><\/span><\/p>\n

a<\/span>divo<\/span> is forging a new era for companion animal health. Our proprietary phage display<\/span> antibody<\/span> libraries deliver species<\/span>–<\/span>specific drugs for a growing market need. We apply our<\/span> extensive drug discovery and protein engineering know<\/span>–<\/span>how to address cancer, chronic<\/span> inflammatory diseases and other serious conditions in pets. Together with our partners,<\/span> we<\/span> create the best possible therapeutics for our beloved furry friends. For further <\/span>information, please visit:<\/span><\/span> www.adivo.vet<\/a>\/.<\/span><\/span><\/span><\/span><\/p>\n

\n
<\/div>\n<\/div>\n

FyoniBio Contact<\/span>:<\/span><\/span>
Dr. Ulrike Scheffler; Senior<\/span> Director Business Development<\/span>
E<\/span>–<\/span>mail:<\/span><\/span> contact@fyonibio.com<\/span><\/span><\/a>
Phone: +49 (0) 17619489825<\/span><\/span>
www.fyonibio.com<\/span><\/a><\/span><\/span><\/span>
a<\/span>divo<\/span> Contact:<\/span><\/span><\/span>
Dr. Kathrin Ladetzki<\/span>–<\/span>Baehs<\/span>, CEO<\/span><\/span>
Phone +49 89 58 8088 471<\/span><\/span>
E<\/span>–<\/span>mail:<\/span><\/span> info@adivo.vet<\/a><\/span><\/span><\/p>\n

 <\/p>\n

Source: FyoniBio<\/span><\/span><\/a><\/em><\/p>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

FyoniBio GmbH, member of the Bio-PAT network, signed a Service Agreement with adivo.It covers the generation of a production cell line for their canine therapeutic mAb candidate. For the project, […]<\/p>\n","protected":false},"author":3,"featured_media":7155,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":[],"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueState":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_VenueShowMap":false,"_VenueShowMapLink":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7149","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allgemein"],"featured_image_src":{"landsacpe":["https:\/\/bio-pat.org\/wp-content\/uploads\/2023\/01\/FyoniBio-Kooperation_adivo.jpg",298,199,false],"list":["https:\/\/bio-pat.org\/wp-content\/uploads\/2023\/01\/FyoniBio-Kooperation_adivo.jpg",298,199,false],"medium":["https:\/\/bio-pat.org\/wp-content\/uploads\/2023\/01\/FyoniBio-Kooperation_adivo.jpg",298,199,false],"full":["https:\/\/bio-pat.org\/wp-content\/uploads\/2023\/01\/FyoniBio-Kooperation_adivo.jpg",298,199,false]},"yoast_head":"\nFyoniBio signed Service Agreement with Adivo GmbH - Bio-PAT<\/title>\n<meta name=\"description\" content=\"FyoniBio signed Service Agreement with Adivo GmbH covering the generation of a production cell line for a canine therapeutic mAb candidate.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FyoniBio signed Service Agreement with Adivo GmbH - Bio-PAT\" \/>\n<meta property=\"og:description\" content=\"FyoniBio signed Service Agreement with Adivo GmbH covering the generation of a production cell line for a canine therapeutic mAb candidate.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh\" \/>\n<meta property=\"og:site_name\" content=\"Bio-PAT\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-11T10:52:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-11T11:03:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neu.bio-pat.org\/wp-content\/uploads\/2023\/01\/FyoniBio-Kooperation_adivo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"298\" \/>\n\t<meta property=\"og:image:height\" content=\"199\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Anika Bockisch\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anika Bockisch\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/bio-pat.org\\\/en\\\/fyonibio-signed-service-agreement-with-adivo-gmbh#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bio-pat.org\\\/en\\\/fyonibio-signed-service-agreement-with-adivo-gmbh\"},\"author\":{\"name\":\"Anika Bockisch\",\"@id\":\"https:\\\/\\\/neu.bio-pat.org\\\/en#\\\/schema\\\/person\\\/974960a088fd4a44cf19ec01374eb82d\"},\"headline\":\"FyoniBio signed Service Agreement with Adivo GmbH\",\"datePublished\":\"2023-01-11T10:52:18+00:00\",\"dateModified\":\"2023-01-11T11:03:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bio-pat.org\\\/en\\\/fyonibio-signed-service-agreement-with-adivo-gmbh\"},\"wordCount\":624,\"image\":{\"@id\":\"https:\\\/\\\/bio-pat.org\\\/en\\\/fyonibio-signed-service-agreement-with-adivo-gmbh#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bio-pat.org\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/FyoniBio-Kooperation_adivo.jpg\",\"articleSection\":[\"Allgemein\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bio-pat.org\\\/en\\\/fyonibio-signed-service-agreement-with-adivo-gmbh\",\"url\":\"https:\\\/\\\/bio-pat.org\\\/en\\\/fyonibio-signed-service-agreement-with-adivo-gmbh\",\"name\":\"FyoniBio signed Service Agreement with Adivo GmbH - Bio-PAT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neu.bio-pat.org\\\/en#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bio-pat.org\\\/en\\\/fyonibio-signed-service-agreement-with-adivo-gmbh#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bio-pat.org\\\/en\\\/fyonibio-signed-service-agreement-with-adivo-gmbh#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bio-pat.org\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/FyoniBio-Kooperation_adivo.jpg\",\"datePublished\":\"2023-01-11T10:52:18+00:00\",\"dateModified\":\"2023-01-11T11:03:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/neu.bio-pat.org\\\/en#\\\/schema\\\/person\\\/974960a088fd4a44cf19ec01374eb82d\"},\"description\":\"FyoniBio signed Service Agreement with Adivo GmbH covering the generation of a production cell line for a canine therapeutic mAb candidate.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bio-pat.org\\\/en\\\/fyonibio-signed-service-agreement-with-adivo-gmbh#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bio-pat.org\\\/en\\\/fyonibio-signed-service-agreement-with-adivo-gmbh\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/bio-pat.org\\\/en\\\/fyonibio-signed-service-agreement-with-adivo-gmbh#primaryimage\",\"url\":\"https:\\\/\\\/bio-pat.org\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/FyoniBio-Kooperation_adivo.jpg\",\"contentUrl\":\"https:\\\/\\\/bio-pat.org\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/FyoniBio-Kooperation_adivo.jpg\",\"width\":298,\"height\":199,\"caption\":\"FyoniBio signed Service Agreement with Adivo GmbH\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bio-pat.org\\\/en\\\/fyonibio-signed-service-agreement-with-adivo-gmbh#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/bio-pat.org\\\/en\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FyoniBio signed Service Agreement with Adivo GmbH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neu.bio-pat.org\\\/en#website\",\"url\":\"https:\\\/\\\/neu.bio-pat.org\\\/en\",\"name\":\"Bio-PAT\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neu.bio-pat.org\\\/en?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neu.bio-pat.org\\\/en#\\\/schema\\\/person\\\/974960a088fd4a44cf19ec01374eb82d\",\"name\":\"Anika Bockisch\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d8bc886b674acebf63d284f8b3d6096890924641c5b2503c2c589662d7d78355?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d8bc886b674acebf63d284f8b3d6096890924641c5b2503c2c589662d7d78355?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d8bc886b674acebf63d284f8b3d6096890924641c5b2503c2c589662d7d78355?s=96&d=mm&r=g\",\"caption\":\"Anika Bockisch\"},\"url\":\"https:\\\/\\\/bio-pat.org\\\/en\\\/author\\\/anika\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FyoniBio signed Service Agreement with Adivo GmbH - Bio-PAT","description":"FyoniBio signed Service Agreement with Adivo GmbH covering the generation of a production cell line for a canine therapeutic mAb candidate.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh","og_locale":"en_US","og_type":"article","og_title":"FyoniBio signed Service Agreement with Adivo GmbH - Bio-PAT","og_description":"FyoniBio signed Service Agreement with Adivo GmbH covering the generation of a production cell line for a canine therapeutic mAb candidate.","og_url":"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh","og_site_name":"Bio-PAT","article_published_time":"2023-01-11T10:52:18+00:00","article_modified_time":"2023-01-11T11:03:31+00:00","og_image":[{"width":298,"height":199,"url":"https:\/\/neu.bio-pat.org\/wp-content\/uploads\/2023\/01\/FyoniBio-Kooperation_adivo.jpg","type":"image\/jpeg"}],"author":"Anika Bockisch","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Anika Bockisch","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh#article","isPartOf":{"@id":"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh"},"author":{"name":"Anika Bockisch","@id":"https:\/\/neu.bio-pat.org\/en#\/schema\/person\/974960a088fd4a44cf19ec01374eb82d"},"headline":"FyoniBio signed Service Agreement with Adivo GmbH","datePublished":"2023-01-11T10:52:18+00:00","dateModified":"2023-01-11T11:03:31+00:00","mainEntityOfPage":{"@id":"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh"},"wordCount":624,"image":{"@id":"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh#primaryimage"},"thumbnailUrl":"https:\/\/bio-pat.org\/wp-content\/uploads\/2023\/01\/FyoniBio-Kooperation_adivo.jpg","articleSection":["Allgemein"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh","url":"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh","name":"FyoniBio signed Service Agreement with Adivo GmbH - Bio-PAT","isPartOf":{"@id":"https:\/\/neu.bio-pat.org\/en#website"},"primaryImageOfPage":{"@id":"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh#primaryimage"},"image":{"@id":"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh#primaryimage"},"thumbnailUrl":"https:\/\/bio-pat.org\/wp-content\/uploads\/2023\/01\/FyoniBio-Kooperation_adivo.jpg","datePublished":"2023-01-11T10:52:18+00:00","dateModified":"2023-01-11T11:03:31+00:00","author":{"@id":"https:\/\/neu.bio-pat.org\/en#\/schema\/person\/974960a088fd4a44cf19ec01374eb82d"},"description":"FyoniBio signed Service Agreement with Adivo GmbH covering the generation of a production cell line for a canine therapeutic mAb candidate.","breadcrumb":{"@id":"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh#primaryimage","url":"https:\/\/bio-pat.org\/wp-content\/uploads\/2023\/01\/FyoniBio-Kooperation_adivo.jpg","contentUrl":"https:\/\/bio-pat.org\/wp-content\/uploads\/2023\/01\/FyoniBio-Kooperation_adivo.jpg","width":298,"height":199,"caption":"FyoniBio signed Service Agreement with Adivo GmbH"},{"@type":"BreadcrumbList","@id":"https:\/\/bio-pat.org\/en\/fyonibio-signed-service-agreement-with-adivo-gmbh#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/bio-pat.org\/en"},{"@type":"ListItem","position":2,"name":"FyoniBio signed Service Agreement with Adivo GmbH"}]},{"@type":"WebSite","@id":"https:\/\/neu.bio-pat.org\/en#website","url":"https:\/\/neu.bio-pat.org\/en","name":"Bio-PAT","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neu.bio-pat.org\/en?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/neu.bio-pat.org\/en#\/schema\/person\/974960a088fd4a44cf19ec01374eb82d","name":"Anika Bockisch","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d8bc886b674acebf63d284f8b3d6096890924641c5b2503c2c589662d7d78355?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d8bc886b674acebf63d284f8b3d6096890924641c5b2503c2c589662d7d78355?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d8bc886b674acebf63d284f8b3d6096890924641c5b2503c2c589662d7d78355?s=96&d=mm&r=g","caption":"Anika Bockisch"},"url":"https:\/\/bio-pat.org\/en\/author\/anika"}]}},"_links":{"self":[{"href":"https:\/\/bio-pat.org\/en\/wp-json\/wp\/v2\/posts\/7149","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bio-pat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bio-pat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bio-pat.org\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/bio-pat.org\/en\/wp-json\/wp\/v2\/comments?post=7149"}],"version-history":[{"count":2,"href":"https:\/\/bio-pat.org\/en\/wp-json\/wp\/v2\/posts\/7149\/revisions"}],"predecessor-version":[{"id":7157,"href":"https:\/\/bio-pat.org\/en\/wp-json\/wp\/v2\/posts\/7149\/revisions\/7157"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bio-pat.org\/en\/wp-json\/wp\/v2\/media\/7155"}],"wp:attachment":[{"href":"https:\/\/bio-pat.org\/en\/wp-json\/wp\/v2\/media?parent=7149"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bio-pat.org\/en\/wp-json\/wp\/v2\/categories?post=7149"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bio-pat.org\/en\/wp-json\/wp\/v2\/tags?post=7149"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}